Trial
NCT01119794
Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Brown University
Collaborators
Rhode Island Hospital; The Miriam Hospital; Memorial Hospital of Rhode Island; Dartmouth-Hitchcock Medical Center
Condition
Lymphoma, Non-Hodgkins
Intervention
Ofatumumab and Bortezomib
Why stopped
lack of accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-08-26